Revere Bank was established on November , by a group of prominent business leaders in the Baltimore Washington corridor. Since our founding, we have enjoyed continuous growth. Our mission is to become the small business bank of choice in each market we serve.
Quote | Revelation Biosciences Inc. (OTCMKTS:REVB)
Last: | $22.52 |
---|---|
Change Percent: | -3.64% |
Open: | $22.41 |
Close: | $22.52 |
High: | $23.06 |
Low: | $21 |
Volume: | 1,500 |
Last Trade Date Time: | 03/31/2020 04:46:33 am |
News | Revelation Biosciences Inc. (OTCMKTS:REVB)
2024-03-22 16:20:06 ET More on Revelation Biosciences Revelation Biosciences to raise ~$6.2M through public offering of shares Seeking Alpha’s Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial informat...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
Message Board Posts | Revelation Biosciences Inc. (OTCMKTS:REVB)
Subject | By | Source | When |
---|---|---|---|
Ready for another move $1.08 entry consideration. $2.05 to | tw0122 | investorshub | 04/18/2023 11:07:48 AM |
Patience gonna pay - this is and still | Klinsmann | investorshub | 04/17/2023 4:04:08 PM |
DOESN'T LOOK IT !! | power11 | investorshub | 04/17/2023 4:02:27 PM |
Agree. Ripe for a VICIOUS reversal. | Lonewolf1 | investorshub | 04/17/2023 3:02:32 PM |
Any update and its going to explode... | Klinsmann | investorshub | 04/17/2023 3:00:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rol...